Genomatica (GENO) Files $100M IPO
Tweet
Share
E-mail
Genomatica, Inc. (Nasdaq: GENO), filed a registration with the U.S. Securities and Exchange Commission for an Initial Public Offering of its Common Stock. The proposed maximum offering price is $100 million. Genomatica plans to list on the Nasdaq Global Market under the ticker "GENO."
The offering is being made through Morgan Stanley, J.P. Morgan, Jefferies, Piper Jaffray, and Raymond James.
Genomatica is a technology leader for the global chemical industry which delivers new, transformative manufacturing processes that enable its partners to produce intermediate and basic chemicals from renewable feedstocks.
The offering is being made through Morgan Stanley, J.P. Morgan, Jefferies, Piper Jaffray, and Raymond James.
Genomatica is a technology leader for the global chemical industry which delivers new, transformative manufacturing processes that enable its partners to produce intermediate and basic chemicals from renewable feedstocks.
Are you missing key trading opportunities? Upgrade to StreetInsider Premium and get a step ahead of the market - FREE TRIAL!
Create E-mail Alert Related Categories
IPOsRelated Entities
Piper Jaffray, JPMorgan, Raymond James, Morgan Stanley, Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
